USX:TARS - Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 21 Jun 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 32.49    +1.06 (+3.37%)

1 May 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Bobak R. Azamian M.D.

IPO: 2020-10-16

Headquarters: US

Employees: 244

Homepage

Description

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms